US drug firm to be quizzed over growth hormoneBMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6954.559 (Published 03 September 1994) Cite this as: BMJ 1994;309:559
- J Roberts
Government agencies in the US are to investigate whether the drug firm, Genentech, has been inducing doctors to prescribe its recombinant human growth hormone to normal children with short stature. The Food and Drug Administration and the Federal Trade Commission will conduct the inquiry.
The drug, marketed as Protropin, is approved for use in children with growth hormone deficiency and chronic renal insufficiency but not in those with short stature that does not have a hormonal cause. But once a drug is on the market doctors can …